Seropositivity to LAV/HTLV-III in 11 European countries

P. Ebbesen, M. Melbye, D. J. Jeffries, J. Antonen, S. L. Valle, J. Suni, A. Ranki, K. Krohn, J. C. Chermann, M. A. Koch, H. Köhler, A. Horváth, K. Nagy, F. Tóth, G. Füst, F. Aiuti, G. Luzi, R. Nájera, A. de la Loma, M. BöttigerP. C. Frei, M. Glauser, J. Stroun, S. Litvinjenko

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The ECP Working Group on AIDS has evaluated data on seropositivity to LAV/HTLV-III supplied by members in 11 Western European countries. The period covered is 1981-1984. The rise in LAV/HTLV seropositivity parallels the incidence of cases of AIDS in the different countries. LAV/HTLV now spreads freely within Europe and spread has become less dependent upon promiscuity. The epidemic is about to enter Eastern Europe. Intravenous drug abusers appear to be the risk group experiencing the most rapid spread at present. Furthermore, seropositivity in males and females outside the traditional risk groups seems on the rise, and as in the US the percentage seronegative in individuals with PGL is quite high. AIDS is rapidly becoming a major cause of cancer in young adults. A coordinated European preventive effort is urgently needed.

Original languageEnglish
Pages (from-to)1453-1456
Number of pages4
JournalEuropean Journal of Cancer and Clinical Oncology
Volume22
Issue number12
DOIs
Publication statusPublished - 1986

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
Eastern Europe
Drug Users
Young Adult
Incidence
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Ebbesen, P., Melbye, M., Jeffries, D. J., Antonen, J., Valle, S. L., Suni, J., ... Litvinjenko, S. (1986). Seropositivity to LAV/HTLV-III in 11 European countries. European Journal of Cancer and Clinical Oncology, 22(12), 1453-1456. https://doi.org/10.1016/0277-5379(86)90078-7

Seropositivity to LAV/HTLV-III in 11 European countries. / Ebbesen, P.; Melbye, M.; Jeffries, D. J.; Antonen, J.; Valle, S. L.; Suni, J.; Ranki, A.; Krohn, K.; Chermann, J. C.; Koch, M. A.; Köhler, H.; Horváth, A.; Nagy, K.; Tóth, F.; Füst, G.; Aiuti, F.; Luzi, G.; Nájera, R.; de la Loma, A.; Böttiger, M.; Frei, P. C.; Glauser, M.; Stroun, J.; Litvinjenko, S.

In: European Journal of Cancer and Clinical Oncology, Vol. 22, No. 12, 1986, p. 1453-1456.

Research output: Contribution to journalArticle

Ebbesen, P, Melbye, M, Jeffries, DJ, Antonen, J, Valle, SL, Suni, J, Ranki, A, Krohn, K, Chermann, JC, Koch, MA, Köhler, H, Horváth, A, Nagy, K, Tóth, F, Füst, G, Aiuti, F, Luzi, G, Nájera, R, de la Loma, A, Böttiger, M, Frei, PC, Glauser, M, Stroun, J & Litvinjenko, S 1986, 'Seropositivity to LAV/HTLV-III in 11 European countries', European Journal of Cancer and Clinical Oncology, vol. 22, no. 12, pp. 1453-1456. https://doi.org/10.1016/0277-5379(86)90078-7
Ebbesen, P. ; Melbye, M. ; Jeffries, D. J. ; Antonen, J. ; Valle, S. L. ; Suni, J. ; Ranki, A. ; Krohn, K. ; Chermann, J. C. ; Koch, M. A. ; Köhler, H. ; Horváth, A. ; Nagy, K. ; Tóth, F. ; Füst, G. ; Aiuti, F. ; Luzi, G. ; Nájera, R. ; de la Loma, A. ; Böttiger, M. ; Frei, P. C. ; Glauser, M. ; Stroun, J. ; Litvinjenko, S. / Seropositivity to LAV/HTLV-III in 11 European countries. In: European Journal of Cancer and Clinical Oncology. 1986 ; Vol. 22, No. 12. pp. 1453-1456.
@article{f1766db62e8d40749b6f476a0d743abd,
title = "Seropositivity to LAV/HTLV-III in 11 European countries",
abstract = "The ECP Working Group on AIDS has evaluated data on seropositivity to LAV/HTLV-III supplied by members in 11 Western European countries. The period covered is 1981-1984. The rise in LAV/HTLV seropositivity parallels the incidence of cases of AIDS in the different countries. LAV/HTLV now spreads freely within Europe and spread has become less dependent upon promiscuity. The epidemic is about to enter Eastern Europe. Intravenous drug abusers appear to be the risk group experiencing the most rapid spread at present. Furthermore, seropositivity in males and females outside the traditional risk groups seems on the rise, and as in the US the percentage seronegative in individuals with PGL is quite high. AIDS is rapidly becoming a major cause of cancer in young adults. A coordinated European preventive effort is urgently needed.",
author = "P. Ebbesen and M. Melbye and Jeffries, {D. J.} and J. Antonen and Valle, {S. L.} and J. Suni and A. Ranki and K. Krohn and Chermann, {J. C.} and Koch, {M. A.} and H. K{\"o}hler and A. Horv{\'a}th and K. Nagy and F. T{\'o}th and G. F{\"u}st and F. Aiuti and G. Luzi and R. N{\'a}jera and {de la Loma}, A. and M. B{\"o}ttiger and Frei, {P. C.} and M. Glauser and J. Stroun and S. Litvinjenko",
year = "1986",
doi = "10.1016/0277-5379(86)90078-7",
language = "English",
volume = "22",
pages = "1453--1456",
journal = "European Journal of Cancer and Clinical Oncology",
issn = "0277-5379",
publisher = "Pergamon Press",
number = "12",

}

TY - JOUR

T1 - Seropositivity to LAV/HTLV-III in 11 European countries

AU - Ebbesen, P.

AU - Melbye, M.

AU - Jeffries, D. J.

AU - Antonen, J.

AU - Valle, S. L.

AU - Suni, J.

AU - Ranki, A.

AU - Krohn, K.

AU - Chermann, J. C.

AU - Koch, M. A.

AU - Köhler, H.

AU - Horváth, A.

AU - Nagy, K.

AU - Tóth, F.

AU - Füst, G.

AU - Aiuti, F.

AU - Luzi, G.

AU - Nájera, R.

AU - de la Loma, A.

AU - Böttiger, M.

AU - Frei, P. C.

AU - Glauser, M.

AU - Stroun, J.

AU - Litvinjenko, S.

PY - 1986

Y1 - 1986

N2 - The ECP Working Group on AIDS has evaluated data on seropositivity to LAV/HTLV-III supplied by members in 11 Western European countries. The period covered is 1981-1984. The rise in LAV/HTLV seropositivity parallels the incidence of cases of AIDS in the different countries. LAV/HTLV now spreads freely within Europe and spread has become less dependent upon promiscuity. The epidemic is about to enter Eastern Europe. Intravenous drug abusers appear to be the risk group experiencing the most rapid spread at present. Furthermore, seropositivity in males and females outside the traditional risk groups seems on the rise, and as in the US the percentage seronegative in individuals with PGL is quite high. AIDS is rapidly becoming a major cause of cancer in young adults. A coordinated European preventive effort is urgently needed.

AB - The ECP Working Group on AIDS has evaluated data on seropositivity to LAV/HTLV-III supplied by members in 11 Western European countries. The period covered is 1981-1984. The rise in LAV/HTLV seropositivity parallels the incidence of cases of AIDS in the different countries. LAV/HTLV now spreads freely within Europe and spread has become less dependent upon promiscuity. The epidemic is about to enter Eastern Europe. Intravenous drug abusers appear to be the risk group experiencing the most rapid spread at present. Furthermore, seropositivity in males and females outside the traditional risk groups seems on the rise, and as in the US the percentage seronegative in individuals with PGL is quite high. AIDS is rapidly becoming a major cause of cancer in young adults. A coordinated European preventive effort is urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=0022887638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022887638&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(86)90078-7

DO - 10.1016/0277-5379(86)90078-7

M3 - Article

C2 - 3474150

AN - SCOPUS:0022887638

VL - 22

SP - 1453

EP - 1456

JO - European Journal of Cancer and Clinical Oncology

JF - European Journal of Cancer and Clinical Oncology

SN - 0277-5379

IS - 12

ER -